Chloroquine Phosphate Market

Chloroquine phosphate (also known as chloroquine) is an antimalarial medicine approved in the United States for either prevention or treatment of certain types of malaria and for treatment of extraintestinal parasites. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. Chloroquine is also occasionally used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. While it has not been formally studied in pregnancy, it appears safe. It is also being studied to treat COVID-19 as of 2020.

Chloroquine Phosphate Market contains market size and forecasts of Chloroquine Phosphate in global, including the following market information:

Global Chloroquine Phosphate Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Chloroquine Phosphate Market Sales, 2017-2022, 2023-2028, (M Units)

Global top five Chloroquine Phosphate companies in 2021 (%)

The global Chloroquine Phosphate market was valued at 139.9 million in 2021 and is projected to reach US$ 62 million by 2028, at a CAGR of -10.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chloroquine Phosphate Injectable Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Chloroquine Phosphate include Sanofi, Bayer, Ipca Laboratories, Cipla, Teva Pharmaceuticals, Merck, AstraZeneca, Pharco Pharmaceuticals and Indofarma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Chloroquine Phosphate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chloroquine Phosphate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Chloroquine Phosphate Market Segment Percentages, by Type, 2021 (%)

• Chloroquine Phosphate Injectable
• Chloroquine Phosphate Oral

Global Chloroquine Phosphate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Chloroquine Phosphate Market Segment Percentages, by Application, 2021 (%)

• Malaria
• COVID-19
• Others

Global Chloroquine Phosphate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Chloroquine Phosphate Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Chloroquine Phosphate revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Chloroquine Phosphate revenues share in global market, 2021 (%)
• Key companies Chloroquine Phosphate sales in global market, 2017-2022 (Estimated), (M Units)
• Key companies Chloroquine Phosphate sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Bayer
• Ipca Laboratories
• Cipla
• Teva Pharmaceuticals
• Merck
• AstraZeneca
• Pharco Pharmaceuticals
• Indofarma
• Jayson Pharmaceuticals
• AM-Europharma
• Humax Pharmaceutical
• Atlantic Pharmaceutical
• Ace Pharmaceuticals BV